KLDO vs. VIVE, GNCA, HTGMQ, ONCSQ, UTRS, AHPI, ATNFW, SXTPW, DRTSW, and APLMW
Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Viveve Medical (VIVE), Genocea Biosciences (GNCA), HTG Molecular Diagnostics (HTGMQ), OncoSec Medical (ONCSQ), Minerva Surgical (UTRS), Allied Healthcare Products (AHPI), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), and Apollomics (APLMW). These companies are all part of the "medical" sector.
Kaleido Biosciences (NASDAQ:KLDO) and Viveve Medical (NASDAQ:VIVE) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.
Viveve Medical has higher revenue and earnings than Kaleido Biosciences.
Viveve Medical received 257 more outperform votes than Kaleido Biosciences when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote.
81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by company insiders. Comparatively, 5.7% of Viveve Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Kaleido Biosciences' average media sentiment score of 0.92 beat Viveve Medical's score of 0.00 indicating that Kaleido Biosciences is being referred to more favorably in the media.
Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.09, indicating that its stock price is 91% less volatile than the S&P 500.
Summary
Viveve Medical beats Kaleido Biosciences on 5 of the 8 factors compared between the two stocks.
Get Kaleido Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kaleido Biosciences Competitors List
Related Companies and Tools
